{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-021213","form_type":"8-K","ticker":"FRMM","cik":"0001690080","company_name":"FORUM MARKETS Inc","filed_at":"2024-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.130714+00:00","generated_at":"2026-06-04T23:52:52.163814+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Sir Marc Feldmann resigns; 180 Life Sciences appoints two independent directors","bullets":["Sir Marc Feldmann resigned as director effective March 7, 2024; not due to any disagreement.","Board appointed Omar Jimenez and Ryan L. Smith as Class II directors, effective March 7, 2024.","Board size set to five; committees reorganized; Jimenez chairs Audit, Smith chairs Compensation & Nominating.","Each new director receives $40k/yr retainer plus $10k chair fees; option for half cash/half stock or all cash with half accrued until $1M raise.","With appointments, board now has majority independent members; all three committees fully independent."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-021213","json":"https://secwatch.observer/filing/0001213900-24-021213.json","markdown":"https://secwatch.observer/filing/0001213900-24-021213.md","text":"https://secwatch.observer/filing/0001213900-24-021213.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1690080/000121390024021213/0001213900-24-021213-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1690080/000121390024021213/ea0201449-8k_180life.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T23:52:52.163814+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"36990d7872","claim":"Sir Marc Feldmann resigned as Director at FORUM MARKETS Inc.","evidence_excerpt":"On March 7, 2023, Sir Marc Feldmann, Ph.D. provided notice to the Board of Directors of 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”) of his resignation as a member of the Board of Directors, effective on the same date (March 7, 2024).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390024021213/0001213900-24-021213-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"65f9b7aee8","claim":"Omar Jimenez was appointed as Director at FORUM MARKETS Inc.","evidence_excerpt":"the Board of Directors of the Company appointed Omar Jimenez and Ryan L. Smith (collectively, the “ Appointees ” and the “ Appointments ”) as members of the Board of Directors (“ Board ”), which Appointments were effective as of the same date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390024021213/0001213900-24-021213-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"a33cb0b926","claim":"Ryan L. Smith was appointed as Director at FORUM MARKETS Inc.","evidence_excerpt":"the Board of Directors of the Company appointed Omar Jimenez and Ryan L. Smith (collectively, the “ Appointees ” and the “ Appointments ”) as members of the Board of Directors (“ Board ”), which Appointments were effective as of the same date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390024021213/0001213900-24-021213-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}